Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deryugina, E. I.
Right arrow Articles by Quigley, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deryugina, E. I.
Right arrow Articles by Quigley, J. P.
[Cancer Research 65, 10959-10969, December 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Unexpected Effect of Matrix Metalloproteinase Down-Regulation on Vascular Intravasation and Metastasis of Human Fibrosarcoma Cells Selected In vivo for High Rates of Dissemination

Elena I. Deryugina, Andries Zijlstra, Juneth J. Partridge, Tatyana A. Kupriyanova, Mark A. Madsen, Thales Papagiannakopoulos and James P. Quigley

Department of Cell Biology, The Scripps Research Institute, La Jolla, California

Requests for reprints: James P. Quigley, Department of Cell Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. Phone: 858-784-7190; Fax: 858-784-7333; E-mail: jquigley{at}scripps.edu.

The human tumor/chick embryo model involving grafting of human HT-1080 fibrosarcoma cells on the chorioallantoic membrane was used in conjunction with quantitative real-time Alu PCR to select in vivo a pair of isogenic cell lines (HT-hi/diss and HT-lo/diss), dramatically differing in their ability to disseminate from the primary tumor (i.e., intravasate into the chorioallantoic membrane vasculature and metastasize to the lungs). During an immunohistochemical time course study, HT-hi/diss cells were sequentially visualized having escaped from the primary tumors, engaged with the blood vessels, and eventually observed inside the chorioallantoic membrane capillaries, thus reflecting early intravasating events. In contrast, HT-lo/diss cells seemed restricted to their primary tumor. Importantly, after i.v. inoculation, both variants arrested, extravasated, and proliferated in host tissues with similar efficiencies, highlighting that the observed earlier events at the periphery of the primary tumor could account for their differential dissemination. In a mechanistic probing of these events, we determined that HT-hi/diss intravasation was sensitive to a broad-range matrix metalloproteinase (MMP) inhibitor. To analyze the possible role of individual MMPs, membrane-bound MMP-14 and secreted MMP-9 were individually down-regulated in HT-hi/diss cells with their corresponding small interfering RNAs. Despite efficient down-regulation of MMP-14, neither intravasation nor metastasis of HT-hi/diss cells was affected significantly. However, a substantial down-regulation of MMP-9 was accompanied by a surprising 3-fold increase in intravasation and metastasis. The results emphasize a rising awareness that targeting certain MMPs might result in an enhanced malignancy, exemplified herein at the intravasation level as this step of the metastatic cascade is dissected and quantified.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
E. M. Conn, K. A. Botkjaer, T. A. Kupriyanova, P. A. Andreasen, E. I. Deryugina, and J. P. Quigley
Comparative Analysis of Metastasis Variants Derived from Human Prostate Carcinoma Cells: Roles in Intravasation of VEGF-Mediated Angiogenesis and uPA-Mediated Invasion
Am. J. Pathol., October 1, 2009; 175(4): 1638 - 1652.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
E. I. Deryugina, E. M. Conn, A. Wortmann, J. J. Partridge, T. A. Kupriyanova, V. C. Ardi, J. D. Hooper, and J. P. Quigley
Functional Role of Cell Surface CUB Domain-Containing Protein 1 in Tumor Cell Dissemination
Mol. Cancer Res., August 1, 2009; 7(8): 1197 - 1211.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Blouse, K. A. Botkjaer, E. Deryugina, A. A. Byszuk, J. M. Jensen, K. K. Mortensen, J. P. Quigley, and P. A. Andreasen
A Novel Mode of Intervention with Serine Protease Activity: TARGETING ZYMOGEN ACTIVATION
J. Biol. Chem., February 13, 2009; 284(7): 4647 - 4657.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Conn, M. A. Madsen, B. F. Cravatt, W. Ruf, E. I. Deryugina, and J. P. Quigley
Cell Surface Proteomics Identifies Molecules Functionally Linked to Tumor Cell Intravasation
J. Biol. Chem., September 26, 2008; 283(39): 26518 - 26527.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. Arnold, E. Mira, S. Muneer, G. Korpanty, A. W. Beck, S. E. Holloway, S. Manes, and R. A. Brekken
Forced Expression of MMP9 Rescues the Loss of Angiogenesis and Abrogates Metastasis of Pancreatic Tumors Triggered by the Absence of Host SPARC
Experimental Biology and Medicine, July 1, 2008; 233(7): 860 - 873.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Redondo-Munoz, E. Ugarte-Berzal, J. A. Garcia-Marco, M. H. del Cerro, P. E. Van den Steen, G. Opdenakker, M. J. Terol, and A. Garcia-Pardo
{alpha}4{beta}1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells
Blood, July 1, 2008; 112(1): 169 - 178.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. Gerg, C. Kopitz, S. Schaten, A. Tschukes, C. Kahlert, M. Stangl, C. W. Hann von Weyhern, B. L.D.M. Brucher, D. R. Edwards, K. Brand, et al.
Distinct Functionality of Tumor Cell-Derived Gelatinases during Formation of Liver Metastases
Mol. Cancer Res., March 1, 2008; 6(3): 341 - 351.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Partridge, M. A. Madsen, V. C. Ardi, T. Papagiannakopoulos, T. A. Kupriyanova, J. P. Quigley, and E. I. Deryugina
Functional Analysis of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Differentially Expressed by Variants of Human HT-1080 Fibrosarcoma Exhibiting High and Low Levels of Intravasation and Metastasis
J. Biol. Chem., December 7, 2007; 282(49): 35964 - 35977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. R. Nair, J. Solway, and D. D. Boyd
Expression Cloning Identifies Transgelin (SM22) as a Novel Repressor of 92-kDa Type IV Collagenase (MMP-9) Expression
J. Biol. Chem., September 8, 2006; 281(36): 26424 - 26436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Madsen, E. I. Deryugina, S. Niessen, B. F. Cravatt, and J. P. Quigley
Activity-based Protein Profiling Implicates Urokinase Activation as a Key Step in Human Fibrosarcoma Intravasation
J. Biol. Chem., June 9, 2006; 281(23): 15997 - 16005.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.